SEARCH

SEARCH BY CITATION

References

  • ARGIOLAS, A. & MELIS, M.R. (1998). The Neuropharmacology of yawning. Eur. J. Pharmacol., 343, 116.
  • ARGIOLAS, A., MELIS, M.R., STANCAMPIANO, R. & GESSA, G.L. (1990). Role of calcium in the expression of ACTH-induced stretching, yawning and penile erection. Brain Res. Bull., 24, 853856.
  • BARTUS, R.T., DEAN, R.L., BEER, B. & LIPPA, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408417.
  • BENTLEY, J.C., MARSDEN, C.A, SLEIGHT, A.J. & FONE, K. C. F. (1997). 5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. British Association for Psychopharmacology Meeting, Cambridge, 13–17th July 1997, P255.
  • BERTOLILI, A. & GESSA, G.L. (1981). Behavioural effects of ACTH and MSH peptides. J. Endocrinol. Invest., 4, 241251.
  • BOESS, F.G, MONSMA, F.J., CAROLO, C., MEYER, V., RUDLER, A., ZWINGELSTEIN, C. & SLEIGHT, A.J. (1997). Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells. Neuropharmacol., 36, 713720.
  • BOESS, F.G., RIEMER, C., BÖS, M., BENTLEY, J., BOURSON, A. & SLEIGHT, A.J. (1998). The selective 5-HT6 receptor radioligand [3H]Ro 63–0563 labels 5-HT receptor binding sites in rat and porcine striatum. Molecular Pharmacol., 54, 577583.
  • BOURSON, A., BORRONI, E., AUSTIN, R., MONSMA, Jr. F.J. & SLEIGHT, A.J. (1995). Determination of the role of the 5-ht6 receptor in the rat brain: A study using antisense oligonucleotides. J. Pharmacol. Exp. Ther., 274, 173180.
  • FERRARI, F., PELLONI, F. & GIULANI, D. (1993). Behavioural evidence that different neurochemical mechanisms underlying stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist. Psychopharmacol., 113, 172176.
  • FERRARI, W., GESSA, G.L. & VARGIU, L. (1963). Behavioural effects induced by intracisternally injected ACTH and MSH. Ann. N. Y. Acad. Sci., 104, 330345.
  • GÉRARD, C., EL MESTIKAWY, S., LEBRAND, C., ADRIEN, J., RUAT, M., TRAIFFORT, E., HAMON, M. & MARTES, M-P. (1996). Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse, 23, 164173.
  • GÉRARD, C., MARTES, M-P., LEFEVRE, K., MIQUEL, M.C., VERGE, D., LANFUMERY, L., DOUCET, E., HAMON, M. & EL MESTIKAWY, S. (1997). Immuno-localization of serotonin 5-ht6 receptor-like material in the rat central nervous system. Brain Res., 746, 207219.
  • GESSA, G.L., PISANO, M., VARGIU, L., CRABI, F. & FERRARI, W. (1967). Stretching and yawning movements after intracerebral injection of ACTH. Rev. Can. Biol., 26, 229236.
  • HERZ, A., TESACHEMACHER, H., HEFSTETTER, A. & KURZ, H. (1965). The importance of lipid-solubility for the central action of cholinolytic drugs. Int. J. Neuropharmacol., 4, 207218.
  • HOYER, D. & MARTIN, G. (1997). 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacol., 36, 419428.
  • IRWIN, S. (1968). Comprehensive observational assessment: Ia. A systematic quantitative procedure for assessing the behavioural and physiological state of the mouse. Psychopharmacologia, 13, 222257.
  • KOHEN, R., METCALF, M.A., KHAN, N., DRUCK, T., HUEBNER, K., LACHOWICZ, J.E., MELTZER, H.Y., SIBLEY, D.R., ROTH, B.R. & HAMBLIN, M.W. (1994). Cloning, characterization and chromosomal localization of a human 5-HT6 serotonin receptor. J. Neurochem., 66, 4756.
  • MONSMA, Jr. F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Molecular. Pharmacol., 43, 320327.
  • POGGIOLO, R., BENELLI, A., ARLETTI, R., CAVAZZUTI, E. & BERTOLINI, A. (1995). Nitric oxide is involved in the ACTH-induced behavioural syndrome. Peptides, 16, 12631268.
  • ROTH, B.L., CRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, Jr. F.J., SHEN, Y., MELTZER, H.Y. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol.Exp.Ther., 268, 4031410.
  • RUAT, M., TRAIFFORT, E., ARRANG, J.M., TARDIVEL-LACOMBE, J., DIAZ, J., LEURS, R. & SCHWARTZ, J.C. (1993). A novel rat serotonin (5-ht6) receptor: molecular cloning, localisation and stimulation of cAMP accumulation. Biochem. Biophys. Res., 193, 268276.
  • SLEIGHT, A.J., BOESS, F.G., BÖS, M., LEVET-TRAFIT, B., RIEMER, C. & BOURSON, A. (1998). Characterisation of Ro 04–6790 and Ro 63–0563: potent and selective antagonists at human and rat 5-HT6 receptors. Brit. J. Pharmacol., 124, 556562.
  • URBA-HOLMGREN, R., GONZALEZ, R. & HOLMGREN, B. (1977). Is yawning a cholinergic response Nature, 267, 261262.
  • WAHLESTEDT, C., GOLANOV, E., YAMAMOTO, S., YEE, F., ERICSON, H., YOO, H., INTRUISI, C.E. & REIS, D.J. (1993a). Antisense oligonucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions. Nature, 363, 260263.
  • WAHLESTEDT, C., PICH, E.M., KOOB, G.F., YEE, F. & HEILIG, M. (1993b). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science, 259, 528531.
  • WARD, R.P., HAMBLIN, M.W., LACHOWICZ, J.E., HOFFMAN, B.J., SIBLEY, D.R. & DORSA, D.M. (1995). Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience, 64, 11051111.
  • YAMADA, K. & FURUKAWA, T. (1980). Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacol., 67, 3943.
  • ZHOU, L-W., ZHANG, S-P., QIN, Z-H. & WEIS, B. (1994). In vivo administration of an oligonucleotide antisense to D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behaviour and the expression of D2 dopamine receptors in mouse striatum. J. Pharmacol. Exp. Ther., 265, 10151023.